Revvity, Inc. (RVTY)

93.08 -0.88 (-0.94%) USD  |  NYSE  |  Apr 20, 09:51
More

Revvity SG&A Expense (Quarterly) : 251.73M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for RVTY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 476.00M
Azenta, Inc. 60.61M
Bruker Corp. 247.20M
Avantor, Inc. 392.40M
Bio-Rad Laboratories, Inc. 221.00M